User profiles for Rajeev Shrestha

Rajeev Shrestha

- Verified email at nepal.inf.org - Cited by 344

Rajeev Shrestha

- Verified email at ynu.ac.kr - Cited by 155

[HTML][HTML] Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses

…, J Ruszkowski, SZM Hussain, R Shrestha… - Globalization and …, 2022 - Springer
Background Apart from infecting a large number of people around the world and causing
the death of many people, the COVID-19 pandemic seems to have changed the healthcare …

[HTML][HTML] The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study

…, J Shakya, K Vaidya, ME Carey, R Shrestha… - The Lancet …, 2022 - thelancet.com
Background The emergence of increasingly antimicrobial-resistant Salmonella enterica
serovar Typhi (S Typhi) threatens to undermine effective treatment and control. Understanding …

Evaluation of conflicts of interest among participants of the Japanese nephrology clinical practice guideline

…, T Sawano, S Shrestha, R Shrestha… - Clinical Journal of the …, 2022 - journals.lww.com
Results Among 142 authors, 125 authors (88%) received $6,742,889 in personal payments
from 56 pharmaceutical companies between 2016 and 2019. Four-year combined median …

[HTML][HTML] Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal

R Shrestha, S Prajapati - Journal of pharmaceutical policy and practice, 2019 - Springer
Background The rational use of medicine improves patient’s quality of life. Excessive and
inappropriate prescriptions result in severe consequences. The study of drug use patterns and …

Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes

…, J Shakya, V Shamanna, J Shastri, R Shrestha… - Elife, 2023 - elifesciences.org
Background: The Global Typhoid Genomics Consortium was established to bring together the
typhoid research community to aggregate and analyse Salmonella enterica serovar Typhi (…

[HTML][HTML] Estimating typhoid incidence from community-based serosurveys: a multicohort study

…, R Shrestha, J Shakya, N Katuwal, S Shrestha… - The Lancet …, 2022 - thelancet.com
Background The incidence of enteric fever, an invasive bacterial infection caused by typhoidal
Salmonellae (Salmonella enterica serovars Typhi and Paratyphi), is largely unknown in …

[HTML][HTML] Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project

…, AM Memon, S Pradhan, K Iqbal, R Shrestha… - The Lancet Global …, 2022 - thelancet.com
Background Precise enteric fever disease burden data are needed to inform prevention and
control measures, including the use of newly available typhoid vaccines. We established the …

Nature and trends in personal payments made to the respiratory physicians by pharmaceutical companies in Japan between 2016 and 2019

…, E Kusumi, B Sapkota, S Shrestha, R Shrestha… - Respiration, 2022 - karger.com
Background: Financial relationships between healthcare professionals and pharmaceutical
companies have historically caused conflicts of interest and unduly influenced patient care. …

[HTML][HTML] Knowledge, attitude, and practice associated with antibiotic use among university students: a survey in Nepal

P Shah, R Shrestha, Z Mao, Y Chen, Y Chen… - International journal of …, 2019 - mdpi.com
The purpose of this study was to conduct a preliminary study to assess knowledge, attitude,
and practice (KAP) associated with antibiotic use among medical students (MS) and non-…

[HTML][HTML] Chlorin e6-associated photodynamic therapy enhances abscopal antitumor effects via inhibition of PD-1/PD-L1 immune checkpoint

P Gurung, J Lim, R Shrestha, YW Kim - Scientific Reports, 2023 - nature.com
We hypothesized that photodynamic therapy (PDT) with Chlorin e6 (Ce6) enhances antitumor
abscopal effects via inhibition of the programmed cell death-1/programmed death-ligand 1 …